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Dectin-1/CLEC7A is a pattern recognition receptor that recognizes β-1,3 glucans, and 
its stimulation initiates signaling events characterized by the production of inflammatory 
cytokines from human dendritic cells (DCs) required for antifungal immunity. β-glucans 
differ greatly in size, structure, and ability to activate effector immune responses from 
DC; as such, small particulate β-glucans are thought to be poor activators of innate 
immunity. We show that β-glucan particle size is a critical factor contributing to the secre-
tion of cytokines from human DC; large β-glucan-stimulated DC generate significantly 
more IL-1β, IL-6, and IL-23 compared to those stimulated with the smaller β-glucans. 
In marked contrast, the secretion of TSLP and CCL22 were found to be insensitive to 
β-glucan particle size. Furthermore, we show that the capacity to induce phagocytosis, 
and the relative IL-1β production determined by β-glucan size, regulates the composition 
of the cytokine milieu generated from DC. This suggests that β-glucan particle size is 
critically important in orchestrating the nature of the immune response to fungi.
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inTrODUcTiOn
Pattern recognition receptor (PRR) signaling pathways are a critical component of innate host 
defense against infectious pathogens. Human dectin-1/CLEC7A is a PRR of the C-type lectin family 
of receptors, predominantly expressed on myeloid-derived cells (1, 2), and recognizes exposed β-1,3 
glucans (β-glucans) present on fungi and bacteria cell walls (3). Engagement of dectin-1 stimulates 
activation of its unconventional immunoreceptor tyrosine activation motif (hemITAM) (3–6), 
followed by subsequent activation of downstream Syk-dependent and -independent signaling 
events (5, 7, 8). The engagement of dectin-1 signaling has been reported to initiate a plethora of 
immunological defense mechanisms including phagocytosis (2, 9, 10), reactive oxygen species 
(ROS) production (6, 8), inflammasome complex activation (8, 11–13), and the release of inflam-
matory cytokines (7, 14–16), required for antifungal immunity.
β-Glucan molecules exhibit heterogeneity in size, structure, and capacity to activate immunologi-
cal effector responses (10, 14, 15, 17, 18). Functional dectin-1 signaling requires the β-glucan to be 
particulate, or in an immobilized form (18), and the size and structure of the β-glucan particulate 
FigUre 1 | β-Glucan particle size differentially affects cytokine secretion by human monocyte-derived dendritic cell (mDC). (a–e) Human mDCs were stimulated 
with curdlan or β-glucan-microparticles (glucan-mp) for 24 h (n = 8 donors), and with curdlan or curdlan-microparticles (curdlan-mp) (n = 7 donors) (F–J) and IL-1β, 
IL-6, IL-23, TSLP, and CCL22 measured by enzyme-linked immunosorbent assay. Cumulative data displayed as mean ±SEM.
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is key to dictating the magnitude of the inflammatory immune 
response initiated by dendritic cells (DCs) in response to 
stimulation (14, 15, 17). It has been suggested that β-glucan size 
controls the capacity of myeloid-derived cells to phagocytose 
fungal products. Therefore, dectin-1-mediated phagocytosis is 
thought to attenuate the production of inflammatory cytokines 
from DC (14, 15), with small particulate β-glucans deemed poor 
activators of innate immunity. Furthermore, fungal species such 
as Candida albicans (C. albicans) exist as both colonizing yeast 
and invasive hyphae, and structural differences exist in β-glucans 
derived from these differing forms—hyphae exhibit a cyclical 
β-glucan structure while yeast β-glucans are linear (17). These 
structural differences have been shown to modulate the produc-
tion of the inflammatory cytokine IL-1β (17) and alter the rate 
of phagocytosis (10), with small β-glucan particulates inducing 
rapid phagocytosis and limited IL-1β. It is well established that 
the production of IL-1β along with IL-6 and IL-23 are required 
for antifungal immunity in part by priming the adaptive immune 
response to induce the differentiation of CD4+ T  cells to TH1/
TH17 cells (3, 12, 16, 19). Therefore, the aim of this study was to 
further investigate how β-glucan size controls dectin-1-mediated 
responses in primary human monocyte-derived dendritic cells 
(mDCs). Patients with chronic granulomatous disease (CGD) are 
unable to generate nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH)-derived ROS. As a result, they have reduced 
antifungal killing activity and suffer from recurrent fungal infec-
tions (20–22). Therefore, a better understanding of how β-glucan 
size regulates key antifungal mechanisms, including the need for 
ROS, could lead to improved management of infection.
We report here that the size of β-glucan particles regulates the 
production of certain cytokines (IL-1β, IL-6, and IL-23), while 
others (TSLP and CCL22) were unaffected by β-glucan size. 
Furthermore, we show that the regulation of IL-1β production 
and phagocytosis, both determined by β-glucan size, provides a 
key molecular checkpoint in eliciting appropriate cytokine secre-
tion from mDC in response to dectin-1 activation.
resUlTs
β-glucan Particle size Differentially 
affects cytokine secretion in human mDc
It has been previously shown that β-glucan particle size sig nificantly 
affects inflammatory cytokine secretion from myeloid-derived 
cells with smaller particulate forms of β-glucan found to be weak 
inducers of cytokine responses. This study aimed to characterize 
further the differences in cytokine responses elicited by either the 
large particulate β-glucan, curdlan (up to 0.2 mm diameter), or 
β-glucan-microparticles (glucan-mp; 1–5  µm diameter) (14), in 
human mDC by measuring IL-1β, IL-6, IL-23, TSLP, and CCL22 
secretion in response to these different stimuli. Characterization of 
both curdlan and glucan-mp by high field 1H-NMR showed these 
β-glucans to have very similar primary structures (Supplementary 
Image 1). mDC stimulated with curdlan produced large amounts 
of IL-1β, IL-6, and IL-23, as compared to glucan-mp stimulated 
mDC secreted much reduced, though still detectable, quantities 
of IL-1β, IL-6, and IL-23 (Figures  1A–C). In marked contrast, 
curdlan- and glucan-mp induced secretion of similar quantities 
of TSLP and CCL22 (Figures  1D,E). However, since curdlan 
FigUre 2 | β-Glucan particle size does not affect activation status of human 
monocyte-derived dendritic cell (mDC). Human mDCs were stimulated with 
either curdlan or glucan-mp for 24 h and CD11c, CD86, and HLA-DR 
expression measured to determine mDC activation by flow cytometry (n = 2 
donors). Gray-filled profile represents unstimulated unstained mDC, the red 
line represents unstimulated stained mDC, the blue line represents 
curdlan-stimulated stained mDC, the green line represents glucan-mp-
stimulated stained mDC.
FigUre 3 | IL-1β, IL-6, IL-23p19, and TSLP mRNA expression by monocyte-derived dendritic cell (mDC) in response to curdlan or β-glucan-microparticles reflects 
cytokine production. (a–h) Human mDCs were stimulated with either curdlan or glucan-mp for 4, 8, or 12 h (n = 2 donors). IL-1β, IL-6, IL-23p19, and TSLP mRNA 
expression were measured by quantitative real-time polymerase chain reaction as relative expression (2−ΔCt), using HPRT expression as a housekeeping gene. Data 
points presented as the mean of replicate values.
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and the glucan-mp were derived from different microorganisms, 
A. faecalis (a Gram-negative bacterium) and the yeast S. cerevisiae, 
respectively, we wished to ensure that the findings were not due 
to differences in the species from which they were prepared. 
Therefore, we produced curdlan microparticles (curdlan-mp), 
using a previously described sonication protocol (14). Once more, 
we observed much reduced amounts of IL-1β, IL-6, and IL-23 in 
response to curdlan-mp as compared to curdlan, but no difference 
in TSLP or CCL22 (Figures 1F–J). Additionally, mDC stimulated 
with curdlan-or glucan-mp displayed no difference in activation 
status, as similar levels of surface expression of CD11c, CD86, 
and HLA-DR were observed (Figure  2). Thus, the results were 
consistent with a difference in the size of the different β-glucan 
preparations affecting cytokine production. To examine whether 
the effects observed were due to differences in gene transcription, 
we also tested whether particle size resulted in similar differences in 
cytokine gene transcription and found that IL-1β, IL-6, IL-23p19, 
and TSLP mRNA expression mirrored the data on secretion of each 
cytokine (Figures  3A–H). Thus, small particles induce reduced 
inflammatory gene transcription compared to larger particles.
The Quantity of il-1β stimulated by a  
β-glucan Particle is a Key Factor That 
Determines the secretion of Other 
cytokines by mDc
Our data suggested that small particulate β-glucans are not 
invariably poor inducers of cytokine secretion, but that certain 
cytokines are more sensitive to the size of the β-glucan particle 
used. Previous work has highlighted the importance of IL-1β 
secretion in orchestrating dectin-1-mediated immune responses 
(12, 16, 23). Therefore, we examined whether the amount of 
FigUre 4 | IL-1β concentration regulates glucan-mp-induced IL-6, IL-23, 
and TSLP secretion in monocyte-derived dendritic cell (mDC). (a) Human 
mDCs were stimulated with curdlan or glucan-mp for 8 h and pro-IL-1β 
protein expression measured by immunoblot (representative experiment 
presented; one of three). (B–e) Human mDC stimulated with glucan-mp and 
recombinant IL-1β simultaneously for 24 h (n = 6 donors). IL-6, IL-23, TSLP, 
and CCL22 were measured by enzyme-linked immunosorbent assay, with 
cumulative data displayed as mean ± SEM.
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IL-1β stimulated by β-glucan particles of different sizes is critical 
in determining the amounts of other cytokines produced. We 
showed that pro-IL-1β protein expression in response to glucan-
mp-stimulation was markedly reduced compared to curdlan 
stimulation (Figure 4A). Furthermore, exogenous recombinant 
IL-1β added at similar concentrations to that produced by cur-
dlan stimulation recovered glucan-mp IL-6 and IL-23 secretion 
to levels equivalent to those produced with curdlan stimulation 
(Figures  4B,C). In contrast, amounts of CCL22 secreted were 
unaffected by addition of exogenous IL-1β (Figure  4E), while 
TSLP secretion was augmented, but only approximately twofold 
(Figure 4D), as compared to the >10-fold increase seen for IL-6 
and IL-23. This result is in agreement with our previous finding 
that there is a requirement for signaling through the IL-1 receptor 
for optimal TSLP production (23). However, it is clear that unlike 
with IL-6 and IL-23, the additional IL-1β generated with curdlan 
stimulation of mDC is not essential for TSLP expression as the 
relatively low amounts of IL-1β produced in response to glucan-
mp are sufficient for substantial secretion of TSLP.
naDPh Oxidase-Derived rOs are 
required for il-1β secretion from mDc 
stimulated with glucan-mp, but not with 
curdlan
Since the amounts of IL-1β produced by mDC in response to large 
and small β-glucan particles differed substantially, we wished to 
examine the signaling requirements for the IL-1β production by 
each form of β-glucan. There are numerous reports showing the 
importance of generation of ROS, and the induction of hypoxia-
inducible factor 1-alpha (HIF-1α), to induce the changes in cellu-
lar metabolism required for IL-1β expression during stimulation 
through dectin-1 (6, 8, 24, 25). We showed that curdlan and 
glucan-mp induced similar quantities of ROS in mDC 
(Figure 5A). They also both induced HIF-1α expression, though 
this was more marked with curdlan (Figure 5B). To determine 
the contribution of NADPH-derived ROS (termed ROS from 
this point) to HIF-1α expression and the induction of IL-1β, we 
generated mDC from patients with CGD; these patients have 
mutations in genes encoding components of the NADPH oxidase 
complex and, therefore, cannot generate ROS. When mDC from 
CGD patients were stimulated with glucan-mp, neither HIF-1α, 
nor pro-IL-1β were detected (Figure  5B), indicating that both 
required NADPH oxidase activity and likely ROS production. In 
contrast, curdlan stimulation induced pro-IL-1β in mDC from 
CGD patients, although this was reduced compared to healthy 
controls, and HIF-1α was not detected, thus indicating a ROS/
HIF-1α-independent mechanism of pro-IL-1β production. 
Accordingly, IL-1β, IL-6, IL-23, and TSLP secretion was effectively 
abolished in mDC from CGD patients responding to glucan-mp, 
but not significantly affected when the same cells responded to 
curdlan (Figures 5C–L). As expected from the findings reported 
above, normal levels of IL-6 (Figure 5I), IL-23 (Figure 5J), and 
near normal levels of TSLP (Figure 5K) were produced by mDC 
from CGD patients responding to curdlan, since sufficient IL-1β 
was produced even in the absence of ROS and HIF-1α induction. 
Both curdlan and glucan-mp-induced CCL22 were insensitive to 
ROS production (Figures 5G,L), with a suggestion of enhanced 
levels from CGD patients. Thus, these experiments showed that 
IL-1β production in response to curdlan proceeds in the absence 
of ROS (and of HIF-1α), whereas this does not occur when 
glucan-mp are used to stimulate mDC.
inhibition of β-glucan internalization 
allows il-1β to Be Produced and Only 
Partially requires naDPh Oxidase-
Derived rOs
As β-glucan size affected the production of IL-1β, and the 
requirement for NADPH oxidase activity to produce IL-1β, we 
FigUre 5 | β-Glucan size affects the requirement for reactive oxygen species (ROS) in IL-1β induction. (a) Human monocyte-derived dendritic cell (mDC) stimulated 
with curdlan or glucan-mp for 8 h. ROS were detected by incubating cells with CellRox Green fluorescence dye and analysis by flow cytometry (representative 
experiment of two) presented, (B) Human mDCs from healthy donors or chronic granulomatous disease (CGD) patients were stimulated with curdlan or glucan-mp 
for 8 h. HIF-1α and pro-IL-1β protein expression measured by immunoblot (n = 2 donors). (c–l) Human mDC from healthy donors or CGD patients were stimulated 
with curdlan or glucan-mp for 24 h (n = 6 donors). IL-1β, IL-6, IL-23, TSLP, and CCL22 secretion were measured by enzyme-linked immunosorbent assay, with 
cumulative data displayed as mean ± SEM.
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investigated the mechanism accounting for the effects of particle 
size. The size of β-glucan particles affects the capacity of murine 
myeloid-derived cells to phagocytose them and induce inflam-
matory cytokines (14, 15). Thus, we treated human mDC with 
cytochalasin D (CYTD) to prevent glucan-mp internalization 
by phagocytosis and found that this substantially increased 
the amounts of IL-1β, IL-6, and IL-23 produced in response to 
glucan-mp, to levels equivalent to those obtained with curdlan 
stimulation; there was a less marked but significant increase in 
TSLP production, but no effect on CCL22 secretion since this 
was already maximal with glucan-mp (Figures 6A–E). Therefore, 
the inhibition of phagocytosis of glucan-mp had the same effect 
as the supplementation of glucan-mp-stimulated mDC cultures 
with exogenous IL-1β. The enhancement of glucan-mp-induced 
cytokine production by CYTD was independent of NADPH oxi-
dase activity and likely ROS production, since mDC from CGD 
patients also produced augmented amounts of these cytokines 
when treated with CYTD (Figures 6F–I). Lack of NADPH oxi-
dase activity had no effect on CCL22 secretion (Figure 6J). To 
further confirm whether these differences were a result of dectin-
1-mediated phagocytosis, we examined the relative capacity of 
curdlan and glucan-mp to induce a decrease in dectin-1 surface 
expression on mDC. Glucan-mp-stimulated mDC induced a 
rapid decrease in surface dectin-1 expression 30 min poststimu-
lation, whereas expression on mDC during curdlan stimulation 
barely changed in comparison to unstimulated stained controls, 
and this expression was maintained 4 h post-curdlan stimulation 
(Figure 7). Moreover, CYTD pretreatment of mDC stimulated 
FigUre 6 | Treatment with cytochalasin D (CYTD) enhances IL-1β induction by monocyte-derived dendritic cell (mDC) from both healthy donors and chronic 
granulomatous disease (CGD) patients stimulated with glucan-mp. (a–e) Human mDCs were preincubated with CYTD for 1 h and then stimulated with glucan-mp 
for 24 h (n = 6 donors). (F–J) Human mDCs derived from CGD patients were preincubated with CYTD for 1 h and then stimulated with glucan-mp for 24 h (n = 3 
donors). IL-1β, IL-6, IL-23, TSLP, and CCL22 were measured by enzyme-linked immunosorbent assay.
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with glucan-mp inhibited dectin-1 internalization (Figure 7) and 
likely prolonged signaling through dectin-1.
It is well established that dectin-1 signaling promotes the dif-
ferentiation of CD4+ T cells to TH1- and TH17-cells (3, 16, 26, 27); 
however, as β-glucan size significantly affected cytokine secretion 
from mDC, we investigated whether this had an impact on CD4+ 
T cell differentiation. CD3/CD28-stimulated naïve CD4+ T cells 
were cultured in supernatants derived from mDC prestimulated 
with either curdlan or glucan-mp. CD4+ T cells cultured in con-
ditioned media derived from curdlan-stimulated mDC produced 
significantly higher levels of IL-17 and IFNγ compared to those 
CD4+ T  cells cultured in conditioned media from glucan-mp 
stimulated mDC (Figures 8A,B). This increased production of 
IL-17 and IFNγ observed in curdlan-treated cells could be rep-
licated when glucan-mp-stimulated mDCs were supplemented 
with recombinant IL-1β (Figures 8C,D).
Together these data show that failure to phagocytose β-glucan 
containing particles, as occurs with curdlan, or with glucan-mp 
in cells treated with CYTD, allows the production of IL-1β in a 
manner independent of NADPH oxidase activity. However, when 
phagocytosis of glucan-mp proceeds normally, the small amounts 
of IL-1β secreted requires NADPH activity, and is, therefore, regu-
lated by an alternative mechanism compared to larger β-glucan 
particles that are not internalized. Therefore, the small amounts 
of IL-1β produced in response to internalized glucan-mp are 
insufficient to allow production of substantial amounts of IL-6 or 
IL-23 and this is the mechanism by which reduced inflammatory 
responses to glucan-mp occur. Furthermore, the differences in 
cytokine milieu generated as a result of β-glucan size modify the 
capacity to drive TH1- and TH17-cell differentiation.
DiscUssiOn
To examine cytokine secretion induced in human mDC through 
dectin-1, we utilized β-glucans of differing size: curdlan (large 
particulate) and glucan-mp (small particulate). Similar to previ-
ous studies in mice (14, 15), we showed that curdlan-stimulated 
human mDC generated significantly more IL-1β, IL-6, and 
IL-23 compared to those stimulated with the smaller glucan-mp, 
and these results reflected particle size since curdlan prepared 
as a small particulate also produced much lower levels of these 
cytokines. In marked contrast, secretion of TSLP and CCL22, fac-
tors associated with TH2 immune responses, were generally unaf-
fected by β-glucan particle size. Importantly, β-glucan particle 
size had little effect on mDC activation status; thus, while small 
β-glucans such as glucan-mp have previously been deemed (from 
murine studies) to be weak inducers of innate immune responses 
(14, 15), our data show that this conclusion cannot be generalized 
to all cytokines and chemokines. We suggest that small β-glucan 
particles will effectively stimulate human TH2 immune responses 
while not favoring more pro-inflammatory responses, including 
TH17 responses, which require IL-6 and IL-23.
FigUre 7 | β-Glucan particle size affects surface dectin-1 expression on 
human monocyte-derived dendritic cell (mDC). Human mDC stimulated with 
either curdlan, glucan-mp, or glucan-mp subsequent to cytochalasin D 
(CYTD) pretreatment, for 30 min or 4 h (n = 2 donors). Dectin-1 expression 
following stimulation was determined relative to unstimulated stained mDC by 
flow cytometry. Gray-filled profile represents unstimulated unstained mDC, 
the red line represents unstimulated stained mDC, the blue line represents 
curdlan stimulated stained mDC, the green line represents glucan-mp 
stimulated stained mDC, and the orange line represents glucan-mp 
stimulated stained mDC subsequent to CYTD pretreatment (note that the 
red, blue, and orange lines essentially overlie each other).
FigUre 8 | Naïve CD4+ T cells produce higher amounts of IL-17 and IFNγ 
when stimulated in conditioned media derived from curdlan-stimulated 
compared to glucan-mp-stimulated monocyte-derived dendritic cell (mDC). 
(a–D) CD3/CD28-stimulated naïve CD4+ T cells were cultured in 
supernatants derived from mDC prestimulated with either curdlan, 
glucan-mp, or glucan-mp supplemented with recombinant IL-1β 
simultaneously for 7 days (n = 4 donors). IL-17 and IFNγ measured by 
enzyme-linked immunosorbent assay. Cumulative data displayed as 
mean ± SEM.
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The different cytokine profiles seen with large and small 
β-glucan particles were shown to be a reflection of the different 
abilities of these stimuli to induce IL-1β. IL-6, and IL-23 required 
the large amounts of IL-1β produced in response to curdlan 
whereas TSLP, while still, as we have previously shown (23, 28), 
requiring IL-1β for its secretion, was produced in substantial 
quantities even in the presence of the small amounts of IL-1β gen-
erated from glucan-mp-stimulated mDC. This suggests that the 
threshold concentration of IL-1β required for TSLP production is 
very low, and much lower than that required for IL-6 and IL-23.
Given the critical difference in the induction of IL-1β by the 
different sized particles, we investigated the mechanism underly-
ing this and showed that phagocytosis was critical. The small 
particulate glucan-mp are phagocytosed readily (14), resulting in 
loss of surface expression of dectin-1. Conversely large particles 
are not phagocytosed, and surface dectin-1 expression is main-
tained. By preventing phagocytosis of glucan-mp with CYTD, we 
inhibited dectin-1 downregulation, completely restored their abil-
ity to induce IL-1β, and hence other cytokines, to the same levels 
as found with curdlan stimulation. We speculate that continued 
surface expression of dectin-1 allows prolonged stimulation 
through the receptor, and hence enhanced production of IL-1β. 
Our data are consistent with Rosas et al. concept that curdlan’s 
capacity to induce elevated inflammatory cytokine expression is 
due to “frustrated phagocytosis” (14), and with the idea that this 
would result in curdlan maintaining dectin-1 expression on the 
cell surface (15).
In relation to the effects of preventing phagocytosis, we 
also noted that induction of IL-1β under these conditions was 
independent of NADPH oxidase activity and most likely ROS 
production, since CYTD treatment fully restored the ability of 
mDC from CGD patients to produce IL-1β. In contrast to this, 
the small amounts of IL-1β induced by glucan-mp from healthy 
donor mDC were completely absent when mDC from CGD 
patients were tested suggesting an alternate mechanism of IL-1β 
production that differs from sustained surface dectin-1 signaling. 
Thus, the attenuated stimulation through dectin-1, which occurs 
when small particle β-glucans are used requires the presence of 
ROS for any IL-1β production. It has previously been shown that 
both curdlan- and glucan-mp-induced IL-1β requires activation 
of caspase-1 and caspase-8, to allow pro-IL-1β cleavage by the 
inflammasome (11, 23). However, with regard to priming of the 
IL-1β response, we clearly showed that glucan-mp resulted in 
much lower levels of pro-IL-1β mRNA and protein expression. 
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Given the critical role of IL-1β in antifungal immunity (3, 12, 16), 
the regulation of its production as determined by β-glucan size 
likely provides a key molecular checkpoint in eliciting appropriate 
cytokine secretion from mDC in response to dectin-1 activation.
These findings give insights into the mechanisms DC utilize to 
orchestrate an effective immune response to fungi. Phagocytosis 
is an effective cellular mechanism for the removal of foreign 
organisms; therefore, it may be advantageous for cells, which are 
capable of phagocytosing fungi, thereby controlling the infec-
tion, to limit their production of inflammatory cytokines such as 
IL-1β that might induce subsequent tissue damage. Pathogenic 
fungal species such as C. albicans exist as both colonizing 
yeast and invasive hyphae and structural differences exist in 
β-glucans derived from these differing forms—hyphae exhibit a 
cyclical β-glucan structure while yeast β-glucans are linear (17). 
Importantly, β-glucan derived from hyphal C. albicans stimulates 
significantly more IL-1β from DC compared to DC stimulated 
with β-glucan from yeast (17). Likewise, it has been reported 
that murine macrophages phagocytose hyphal C. albicans more 
slowly than a strain of C. albicans, which is maintained in a yeast 
form, and prevented from forming hyphae; under these circum-
stances, the macrophages exhibit frustrated phagocytosis (10).
Our data clearly showed that NADPH oxidase activity and 
ROS were not required for IL-1β production when phagocytosis 
was prevented. Previously, de Luca et al. also reported that ROS 
were not required for induction of IL-1β by C. albicans or LPS-
primed macrophages (21), but they did not state what form of 
C. albicans was used in these experiments. Our data would be 
consistent with their using hyphal C. albicans and hence induc-
tion of frustrated phagocytosis and induction of IL-1β independ-
ent of ROS.
There are significant in  vivo implications of our findings. 
Dectin-1-stimulated DC potently drive the differentiation 
of naïve CD4+ T  cells to TH1- and TH17-cells required for 
protective antifungal immunity, and IL-1β, IL-6, and IL-23 are 
important in generating these T cell subsets. Our data show that 
naïve CD4+ T cells produce higher amounts of IL-17 and IFNγ 
when stimulated in conditioned media derived from curdlan-
stimulated mDC compared to those stimulated with glucan-mp. 
Therefore, when DC (or macrophages) are confronted with non-
invasive yeast, they can clear the infection by rapid phagocytosis, 
especially macrophages, and limited production of IL-1β, and 
hence in the case of mDC, which respond to autocrine and 
macrophage-derived IL-1β IL-6 and IL-23. Conversely, when 
confronted with invasive hyphal fungi, phagocytosis will be 
frustrated and an enhanced cytokine response produced with 
elevated macrophage and mDC production of IL-1β and hence 
elevated mDC production of IL-6 and IL-23. This in turn will 
be a critical factor in the stimulation of the TH1 and TH17 adap-
tive immune responses needed to clear this more threatening 
infection.
MaTerials anD MeThODs
ethics statement
Human blood was sourced from apheresis cones derived from 
healthy donors (Addenbrooke’s Hospital, Cambridge) and 
age- and sex-matched CGD patients (Royal Free Hospital, 
London). Appropriate consent to use blood-derived cells for 
research was obtained. Ethics Reference Number: 04/Q0501/119.
β-glucan isolation and characterization
β-Glucan was isolated from S. cerevisiae using a modification of 
the method of Williams et al. as described by Mueller and col-
leagues (29, 30). Specifically, phosphoric acid was used instead 
of hydrochloric acid in the protic acid digestion step. This 
approach results in a highly pure glucan, but with less degra-
dation of the glucan polymer structure. The glucan was char-
acterized by 1H-NMR as described by Lowman et al. (17). The 
glucan (~20 mg) was dissolved in 700 µl of deuterated DMSOd6. 
Approximately 50 µl of TFA was added to shift the water peak 
away from the carbohydrate spectral region. The 1H-NMR spec-
tra were obtained at 80°C. S. cerevisiae glucan was determined 
to be >95% pure based on the 1D 1H-NMR and comparison to 
an ultrapure (>97%) glucan reference standard produced in the 
Williams laboratory.
cell isolation and generation of mDcs
Human blood was sourced from healthy donors (Addenbrooke’s 
Hospital, Cambridge) and age, sex-matched CGD patients 
(Royal Free Hospital, London). Human mDCs were generated 
from CD14+ monocytes isolated from PBMC by magnetic bead 
separation (Miltenyi) and were differentiated by culturing for 
6 days in RPMI1640 (Lonza) supplemented 5% FCS (Biosera), 
20  ng/ml GM-CSF (Life Technologies) and 4  ng/ml IL-4 (BD 
Biosciences) as described previously (23, 31, 32). Naïve human 
CD4+ T  cells were isolated by magnetic bead separation 
(Miltenyi).
stimulation of mDc
Monocyte-derived dendritic cells were stimulated with 50 µg/ml 
of curdlan (Wako), curdlan microparticles (curdlan-mp) [gener-
ated as described previously (14)], and β-1,3 glucan microparti-
cles (glucan-mp) [generated as described above (29, 30)]. mDCs 
were also stimulated with β-glucans and 2  µM CYTD (Sigma) 
and/or 10 ng/ml IL-1β (Miltenyi) simultaneously. Cell cultures 
were incubated for predefined time periods as highlighted in 
figure legends.
Differentiation of naïve cD4+ T cells
Naïve CD4+ T  cells were stimulated with anti-CD3/anti-CD28 
activation beads (1:1 ratio) (ThermoFisher) and 20  IU of IL-2 
(Becton Dickinson) for 7  days in the presence of supernatants 
derived from mDC prestimulated with either 50 µg/ml of curdlan 
or glucan-mp. CD4+ T cell culture supernatants were subsequently 
harvested to evaluate IL-17 and IFNγ secretion.
cytokine analysis by enzyme-linked 
immunosorbent assay (elisa)
Enzyme-linked immunosorbent assays were performed using 
appropriate optimized kits for IL-1β, IL-6, IL-23, IL-17, IFNγ 
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(eBioscience), TSLP, and CCL22 (R&D) according to the manu-
facturers’ instructions. Briefly, plates were precoated with capture 
antibody overnight and washed five times with wash buffer com-
posed of 1× PBS supplemented with 0.05% Tween 20 (Sigma). This 
wash protocol was repeated between each protocol step. ELISA 
plates were then blocked followed by addition of experimental 
supernatants or standards. Plates were then treated with bioti-
nylated detection antibodies followed by avidin-horseradish per-
oxidase. 3,3 ′,5,5′-tetramethylbenzidine substrate (eBioscience) 
was added to each well, with the reaction developed for 
10–15 min in the dark. ELISA plates were read at a wavelength 
of 450  nm with cytokine concentrations calculated using the 
standard curve values.
rna isolation and Quantitative real-time 
Polymerase chain reaction (qrT-Pcr)
Total RNA was isolated using commercial RNAeasy kits 
(Bioline) according to the manufacturer’s instructions. mDCs 
were initially stimulated for 4, 8, or 12  h, supernatants were 
removed, and cells lysed in lysis buffer. Briefly, lysates were 
homogenized, placed into spin columns, washed, and centri-
fuged with commercial diluents and RNA was eluted from the 
spin columns. qRT-PCR was carried out using TaqMan Gene 
Expression Assays (Applied Biosystems) for IL-1β, IL-6, IL-23, 
TSLP, and HPRT. RNA was added to master mix consisting 
of commercial gene specific probe and primer sets (Applied 
Biosystems), TaqMan® Universal PCR Master Mix, reverse 
transcriptase and RNase free H2O. Taqman reactions were run 
for 40 cycles on a predefined temperature cycling program. 
Gene expression for cytokines were normalized to expression of 
the house-keeping gene, HPRT, and calculated as either relative 
expression (2−ΔCt) from unstimulated control cells.
cell lysis, sodium Dodecyl sulfate (sDs)-
Polyacrylamide gel electrophoresis 
(Page), and immunoblotting
Monocyte-derived dendritic cells were lysed in cytoplasmic 
lysis buffer [10  mM HEPES, 50  mM NaCl, 0.5  M Sucrose, 
0.1  mM EDTA, 0.5% v/v Triton X-100, 10  mM Tetrasodium 
pyrophosphate, 17.5 mM β-glycerophosphate (all from Sigma) 
and one complete mini protease inhibitor cocktail tablet 
(Roche)]. Cellular lysates were scraped, and frozen at −20°C 
overnight before thawing to aid cell lysis. Lysates were centri-
fuged at 16,000 g at 4°C and the cytoplasmic supernatant was 
separated from the nuclear pellet. Total protein was quantified 
by Bradford Assay (Thermo). SDS-PAGE was used to resolve 
proteins. Equivalent concentrations of protein lysate were 
mixed with 6× loading buffer (10% w/v SDS, 0.3 M Tris–HCl, 
25% v/v β-Mercaptoethanol) and glycerol (all from Sigma) and 
boiled for 10  min. Samples and molecular weight reference 
proteins were loaded on to precast gradient (4–20%) acrylamide 
gels (BioRad) and run for 90  min at constant amps (30  mA). 
Resolved proteins were detected after transfer to nitrocel-
lulose membranes by immunoblot. Membranes were blocked 
in 5% milk (w/v) (Marvel) and washed three times with wash 
buffer composed of 1× TBS supplemented with 0.1% Tween 20 
between each protocol step. Membranes were then probed with 
primary antibodies to pro-IL-1β (R&D, AB-201-AB), HIF-1α 
(Novus, NB100-449), and β-actin (Abcam) overnight, and then 
incubated in HRP-conjugated secondary antibodies. Protein 
was detected with ECL (PerkinElmer) and visualized using 
GBox (Syngene). Protein expression was analyzed relative to 
β-actin control.
Flow cytometry
Flow cytometry was used to determine mDC activation status, 
dectin-1 expression, and ROS production. For mDC activation 
status and dectin-1 expression, mDC were resuspended in FACS 
buffer consisting of PBS supplemented with 0.1% BSA, 2  mM 
EDTA, and 0.01% Sodium Azide (All Sigma) after stimulation. 
ROS were detected by incubating mDC with CellRox Green 
(Thermo) fluorescence dye during stimulations as per manufac-
turer’s instructions; followed by harvesting into FACS buffer. mDC 
were then treated with 10% mouse serum (Sigma) for 30 min on 
ice to block non-specific binding of antibodies to Fc receptors. 
mDCs were then stained for 30  min with anti-CD11c (Becton 
Dickinson, Clone B-ly6), anti-CD86 (Biolegend Clone IT2.2), and 
anti-HLA-DR (Becton Dickinson, Clone 946.6) to examine mDC 
activation status and anti-dectin-1 (R&D Systems, Clone 259931) 
to determine dectin-1 downregulation. Cells were then washed, 
centrifuged at 300 g for 5 min, and re-suspended in FACS buffer for 
analysis. mDC expression of CD11c, CD86, HLA-DR, dectin-1, and 
ROS was determined by mean fluorescence intensity and acquired 
using a flow cytometer (FACSFortessa, Becton Dickinson).
Data analysis
Cumulative data displayed as mean ± SEM. Data were analyzed 
using the Prism statistical package (GraphPad) with statistical 
analysis completed using one-way ANOVA with Bonferroni post-
tests (ns = not significant, ****p = 0.001,***p = 0.01, **p = 0.05, 
*p = 0.1). Flow cytometry data were analyzed using FlowJo 10 
software (Treestar).
eThics sTaTeMenT
Human blood was sourced from apheresis cones derived from 
healthy donors (Addenbrooke’s Hospital, Cambridge) and age- 
and sex-matched CGD patients (Royal Free Hospital, London). 
Appropriate consent to use blood-derived cells for research was 
obtained. Ethics Reference Number: 04/Q0501/119.
aUThOr cOnTriBUTiOns
ME: designed, performed, and analyzed all experimental data 
and drafted the manuscript. SW: key to experimental design, 
data interpretation, and reviewed manuscript. RC: facilitated 
access to patient blood. Aided data interpretation and reviewed 
manuscript. DW: facilitated access to β-glucan agonists. Aided 
experimental design, data interpretation, and reviewed manu-
script. JSHG: key to experimental design, data interpretation, 
10
Elder et al. β-Glucan Size Controls Dectin-1 Responses
Frontiers in Immunology | www.frontiersin.org July 2017 | Volume 8 | Article 791
and reviewed manuscript. JG: key to experimental design, data 
interpretation, and reviewed manuscript.
acKnOWleDgMenTs
We would like to thank L. Ellis, T. J. Fitzmaurice, D. Lowman, and 
Z. Ma for their technical assistance during this project. We would 
like to thank Sarita Workman for her help with the sample collec-
tion. This research was supported by Arthritis Research UK and 
the Cambridge NIHR BRC Cell Phenotyping Hub. This research 
was also supported, in part, by NIH GM53522, GM083016, 
GM119197, and C06RR0306551 to DW.
sUPPleMenTarY MaTerial
The Supplementary Material for this article can be found 
online at http://journal.frontiersin.org/article/10.3389/fimmu. 
2017.00791/full#supplementary-material.
reFerences
1. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, 
et  al. The beta-glucan receptor, dectin-1, is predominantly expressed on 
the surface of cells of the monocyte/macrophage and neutrophil lineages. 
J Immunol (2002) 169(7):3876–82. doi:10.4049/jimmunol.169.7.3876 
2. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-
Pomares L, et al. Dectin-1 is a major beta-glucan receptor on macrophages. 
J Exp Med (2002) 196(3):407–12. doi:10.1084/jem.20020470 
3. Goodridge HS, Wolf AJ, Underhill DM. Beta-glucan recognition 
by the innate immune system. Immunol Rev (2009) 230(1):38–50. 
doi:10.1111/j.1600-065X.2009.00793.x 
4. Herre J, Marshall AS, Caron E, Edwards AD, Williams DL, Schweighoffer E, 
et al. Dectin-1 uses novel mechanisms for yeast phagocytosis in macrophages. 
Blood (2004) 104(13):4038–45. doi:10.1182/blood-2004-03-1140 
5. Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, 
et al. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern 
recognition pathway for C type lectins. Immunity (2005) 22(4):507–17. 
doi:10.1016/j.immuni.2005.03.004 
6. Underhill DM, Rossnagle E, Lowell CA, Simmons RM. Dectin-1 activates 
Syk tyrosine kinase in a dynamic subset of macrophages for reactive oxygen 
production. Blood (2005) 106(7):2543–50. doi:10.1182/blood-2005-03-1239 
7. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Wevers B, Bruijns SC, 
et  al. Dectin-1 directs T helper cell differentiation by controlling nonca-
nonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol (2009) 
10(2):203–13. doi:10.1038/ni.1692 
8. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, et al. 
Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host 
defence. Nature (2009) 459(7245):433–6. doi:10.1038/nature07965 
9. Janusz MJ, Austen KF, Czop JK. Isolation of soluble yeast beta-glucans that 
inhibit human monocyte phagocytosis mediated by beta-glucan receptors. 
J Immunol (1986) 137(10):3270–6. 
10. Lewis LE, Bain JM, Lowes C, Gillespie C, Rudkin FM, Gow NA, et al. Stage 
specific assessment of Candida albicans phagocytosis by macrophages iden-
tifies cell wall composition and morphogenesis as key determinants. PLoS 
Pathog (2012) 8(3):e1002578. doi:10.1371/journal.ppat.1002578 
11. Gringhuis SI, Kaptein TM, Wevers BA, Theelen B, van der Vlist M, Boekhout T, 
et al. Dectin-1 is an extracellular pathogen sensor for the induction and pro-
cessing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 
(2012) 13(3):246–54. doi:10.1038/ni.2222 
12. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, et  al. An 
essential role for the NLRP3 inflammasome in host defense against the human 
fungal pathogen Candida albicans. Cell Host Microbe (2009) 5(5):487–97. 
doi:10.1016/j.chom.2009.05.002 
13. Ganesan S, Rathinam VA, Bossaller L, Army K, Kaiser WJ, Mocarski ES, et al. 
Caspase-8 modulates dectin-1 and complement receptor 3-driven il-1beta 
production in response to beta-glucans and the fungal pathogen, Candida 
albicans. J Immunol (2014) 193(5):2519–30. doi:10.4049/jimmunol.1400276 
14. Rosas M, Liddiard K, Kimberg M, Faro-Trindade I, McDonald JU, Williams DL, 
et  al. The induction of inflammation by dectin-1 in  vivo is dependent on 
myeloid cell programming and the progression of phagocytosis. J Immunol 
(2008) 181(5):3549–57. doi:10.4049/jimmunol.181.5.3549 
15. Hernanz-Falcon P, Joffre O, Williams DL, Reis e Sousa C. Internalization of 
dectin-1 terminates induction of inflammatory responses. Eur J Immunol 
(2009) 39(2):507–13. doi:10.1002/eji.200838687 
16. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, Gattorno M, 
et  al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 
and are regulated by IL-1beta. Nature (2012) 484(7395):514–8. doi:10.1038/
nature10957 
17. Lowman DW, Greene RR, Bearden DW, Kruppa MD, Pottier M, 
Monteiro MA, et al. Novel structural features in Candida albicans hyphal glu-
can provide a basis for differential innate immune recognition of hyphae ver-
sus yeast. J Biol Chem (2014) 289(6):3432–43. doi:10.1074/jbc.M113.529131 
18. Goodridge HS, Reyes CN, Becker CA, Katsumoto TR, Ma J, Wolf AJ, et al. 
Activation of the innate immune receptor dectin-1 upon formation of a ‘phago-
cytic synapse’. Nature (2011) 472(7344):471–5. doi:10.1038/nature10071 
19. Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, et al. 
Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense 
against Aspergillus fumigatus. J Immunol (2009) 182(8):4938–46. doi:10.4049/
jimmunol.0804250 
20. Falcone EL, Holland SM. Invasive fungal infection in chronic granulomatous 
disease: insights into pathogenesis and management. Curr Opin Infect Dis 
(2012) 25(6):658–69. doi:10.1097/QCO.0b013e328358b0a4 
21. de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, 
et  al. IL-1 receptor blockade restores autophagy and reduces inflammation 
in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci 
U S A (2014) 111(9):3526–31. doi:10.1073/pnas.1322831111 
22. Meissner F, Seger RA, Moshous D, Fischer A, Reichenbach J, Zychlinsky A. 
Inflammasome activation in NADPH oxidase defective mononuclear 
phagocytes from patients with chronic granulomatous disease. Blood (2010) 
116(9):1570–3. doi:10.1182/blood-2010-01-264218 
23. Elder MJ, Webster SJ, Williams DL, Gaston JS, Goodall JC. TSLP production by 
dendritic cells is modulated by IL-1beta and components of the endoplasmic 
reticulum stress response. Eur J Immunol (2016) 46(2):455–63. doi:10.1002/
eji.201545537 
24. Cheng SC, Quintin J, Cramer RA, Shepardson KM, Saeed S, Kumar V, 
et  al. mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic 
basis for trained immunity. Science (2014) 345(6204):1250684. doi:10.1126/
science.1250684 
25. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, 
Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through 
HIF-1alpha. Nature (2013) 496(7444):238–42. doi:10.1038/nature11986 
26. van de Veerdonk FL, Joosten LA, Shaw PJ, Smeekens SP, Malireddi RK, 
van der Meer JW, et  al. The inflammasome drives protective Th1 and 
Th17  cellular responses in disseminated candidiasis. Eur J Immunol (2011) 
41(8):2260–8. doi:10.1002/eji.201041226 
27. Lemoine S, Jaron B, Tabka S, Ettreiki C, Deriaud E, Zhivaki D, et al. Dectin-1 
activation unlocks IL12A expression and reveals the TH1 potency of neo-
natal dendritic cells. J Allergy Clin Immunol (2015) 136(5):1355–68.e1–15. 
doi:10.1016/j.jaci.2015.02.030 
28. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al. Endoplasmic 
reticulum stress-induced transcription factor, CHOP, is crucial for dendritic 
cell IL-23 expression. Proc Natl Acad Sci U S A (2010) 107(41):17698–703. 
doi:10.1073/pnas.1011736107 
29. Muller A, Ensley H, Pretus H, McNamee R, Jones E, McLaughlin E, et  al. 
The application of various protic acids in the extraction of (1→3)-beta-D-
glucan from Saccharomyces cerevisiae. Carbohydr Res (1997) 299(3):203–8. 
doi:10.1016/S0008-6215(97)00004-9 
30. Williams DL, McNamee RB, Jones EL, Pretus HA, Ensley HE, Browder IW, 
et al. A method for the solubilization of a (1→3)-beta-D-glucan isolated from 
11
Elder et al. β-Glucan Size Controls Dectin-1 Responses
Frontiers in Immunology | www.frontiersin.org July 2017 | Volume 8 | Article 791
Saccharomyces cerevisiae. Carbohydr Res (1991) 219:203–13. doi:10.1016/ 
0008-6215(91)89052-H 
31. Webster SJ, Ellis L, O’Brien LM, Tyrrell B, Fitzmaurice TJ, Elder MJ, et  al. 
IRE1alpha mediates PKR activation in response to Chlamydia tracho-
matis infection. Microbes Infect (2016) 18(7–8):472–83. doi:10.1016/j.
micinf.2016.03.010 
32. Webster SJ, Brode S, Ellis L, Fitzmaurice TJ, Elder MJ, Gekara NO, et  al. 
Detection of a microbial metabolite by STING regulates inflammasome 
activation in response to Chlamydia trachomatis infection. PLoS Pathog (2017) 
13(6):e1006383. doi:10.1371/journal.ppat.1006383 
Conflict of Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2017 Elder, Webster, Chee, Williams, Hill Gaston and Goodall. This is an 
open-access article distributed under the terms of the Creative Commons Attribution 
License (CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use, 
distribution or reproduction is permitted which does not comply with these terms.
